We are live on ! Find out more
SAGE

Sage Therapeutics
SAGE

Delisted

SAGE was delisted on the 30th of July, 2025.

Back to rankings

5 hedge funds and large institutions have $494K invested in Sage Therapeutics in 2025 Q3 according to their latest regulatory filings, with 0 funds opening new positions, 2 increasing their positions, 1 reducing their positions, and 185 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% more repeat investments, than reductions

Existing positions increased: 2 | Existing positions reduced: 1

77.93% less ownership

Funds ownership: 78.02% → 0.09% (-78%)

97% less funds holding

Funds holding: 191 → 5 (-186)

100% less capital invested

Capital invested by funds: $446M → $494K (-$445M)

100% less funds holding in top 10

Funds holding in top 10: 5 → 0 (-5)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 185

Holders
5
Holders Change
-186
Holders Change %
-97.38%
% of All Funds
0.07%
Holding in Top 10
–
Holding in Top 10 Change
-5
Holding in Top 10 Change %
-100%
% of All Funds
–
New
–
Increased
2
Reduced
1
Closed
185
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
XT
XTX Topco
Cayman Islands
+$150K
2
IA
IFP Advisors
Florida
+$45

Top Sellers

Rank Fund Capital Flow
1
MAP
Madison Avenue Partners
New York
-$55.4M
2
BlackRock
BlackRock
New York
-$41.5M
3
Vanguard Group
Vanguard Group
Pennsylvania
-$29.8M
4
Hudson Bay Capital Management
Hudson Bay Capital Management
Connecticut
-$17.8M
5
D.E. Shaw & Co
D.E. Shaw & Co
New York
-$17.5M
Name Holding Trade Value Shares
Change 		Change in
Stake
Mariner
101
Mariner
Kansas
– -$311K -34,150 Closed
MIM
102
MetLife Investment Management
New Jersey
– -$311K -34,106 Closed
Wealth Enhancement Advisory Services
103
Wealth Enhancement Advisory Services
Minnesota
– -$313K -34,046 Closed
CGIM
104
Cannon Global Investment Management
Florida
– -$296K -32,500 Closed
Mirae Asset Global ETFs Holdings
105
Mirae Asset Global ETFs Holdings
Hong Kong
– -$286K -31,380 Closed
Russell Investments Group
106
Russell Investments Group
United Kingdom
– -$267K -29,307 Closed
EAM
107
Erste Asset Management
Austria
– -$261K -28,500 Closed
IIM
108
INTECH Investment Management
Florida
– -$251K -27,541 Closed
Cambridge Investment Research Advisors
109
Cambridge Investment Research Advisors
Iowa
– -$250K -27,432 Closed
ECM
110
ExodusPoint Capital Management
New York
– -$238K -26,125 Closed
FT
111
Fiduciary Trust
Massachusetts
– -$237K -25,999 Closed
Universal-Beteiligungs- und Servicegesellschaft
112
Universal-Beteiligungs- und Servicegesellschaft
Germany
– -$233K -25,600 Closed
Creative Planning
113
Creative Planning
Kansas
– -$229K -25,143 Closed
QOP
114
Quinn Opportunity Partners
Virginia
– -$227K -24,888 Closed
VFA
115
Values First Advisors
Tennessee
– -$203K -22,296 Closed
Manulife (Manufacturers Life Insurance)
116
Manulife (Manufacturers Life Insurance)
Ontario, Canada
– -$190K -20,880 Closed
AC
117
AXQ Capital
New Jersey
– -$184K -20,152 Closed
Squarepoint
118
Squarepoint
New York
– -$177K -19,389 Closed
Wolverine Trading
119
Wolverine Trading
Illinois
– -$168K -18,390 Closed
A
120
AlphaQuest
New York
– -$155K -17,003 Closed
PCA
121
Pallas Capital Advisors
Massachusetts
– -$147K -16,095 Closed
Bank of Montreal
122
Bank of Montreal
Ontario, Canada
– -$141K -15,467 Closed
VOYA Investment Management
123
VOYA Investment Management
Georgia
– -$140K -15,328 Closed
State Board of Administration of Florida Retirement System
124
State Board of Administration of Florida Retirement System
Florida
– -$138K -15,164 Closed
PFSRSONJ
125
Police & Firemen's Retirement System of New Jersey
New Jersey
– -$127K -13,963 Closed
3 4
5
6 7

SAGE Hedge Fund Activity: Q3 2025 in Review

5 of the 7,620 institutional investors tracked by Wall St. Rank reported a position in Sage Therapeutics (SAGE) for Q3 2025, worth a combined $494K — down 100% from $446M a quarter earlier.

Sellers outnumbered buyers: 185 funds closed out of SAGE and 0 opened new positions — a net loss of 185 holders — while 1 trimmed existing stakes and 2 added.

The largest buyer was XTX Topco, adding an estimated $150K. The largest seller was Madison Avenue Partners, exiting entirely with an estimated $55.4M sold.

  • 5 institutional investors held Sage Therapeutics (SAGE) as of Q3 2025, down from 191 in Q2 2025.
  • Funds reported $494K of Sage Therapeutics stock for Q3 2025, down 100% quarter-over-quarter.
  • 0 funds opened new Sage Therapeutics positions in Q3 2025 and 185 closed out, a net change of -185 holders.
  • The largest Sage Therapeutics buyer in Q3 2025 was XTX Topco, an estimated $150K added.
  • The largest Sage Therapeutics seller in Q3 2025 was Madison Avenue Partners, an estimated $55.4M sold.

Based on aggregated 13F filings for Q3 2025.